Issues in second trimester induced abortion (medical/surgical methods)

被引:19
|
作者
Lee, Vivian C. Y. [1 ]
Ng, Ernest H. Y. [1 ]
Ho, P. C. [1 ]
机构
[1] Univ Hong Kong, Dept Obstet & Gynaecol, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
关键词
second trimester abortion; dilation and evacuation; mifepristone; misoprostol; 2ND-TRIMESTER SURGICAL ABORTION; RANDOMIZED CONTROLLED-TRIAL; INTRAVAGINAL MISOPROSTOL; PREGNANCY TERMINATION; VAGINAL MISOPROSTOL; MEDICAL TERMINATION; CERVICAL-DILATION; UTERINE RUPTURE; MIDTRIMESTER-ABORTION; MIFEPRISTONE RU-486;
D O I
10.1016/j.bpobgyn.2010.02.008
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Second trimester abortion remains a common procedure worldwide Dilatation and evacuation (D&E) is the surgical method of choice, if the surgical expertise and facilities are available Adequate cervical dilatation preoperatively is a prerequisite for a safe D&E Medical abortion using misoprostol together with mifepristone is the medical method of choice. The recommended regimen is 200 mg mifepristone followed by 800 mu g of vaginal misoprostol 36-48 h later Subsequent doses of 400 mu g of misoprostol can be given orally every 3 h up to a maximum of four more doses Proper preoperative assessment would not only help to provide safe abortion treatment. but it also guides the choice of method If the expertise and facilities of both methods are available, both methods should be discussed and offered to the patient so that the patient can make an informed choice (C) 2010 Elsevier Ltd. All rights reserved
引用
收藏
页码:517 / 527
页数:11
相关论文
共 50 条
  • [41] Rupture of the cervix in a sulprostone induced abortion in the second trimester
    Corrado, F
    D'Anna, R
    Cannata, ML
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2000, 264 (03) : 162 - 163
  • [42] Uterine rupture disguised by urinary retention following a second trimester induced abortion: a case report
    Jiang, Qiaoying
    Yang, Liwei
    Ashley, Charles
    Medlin, Erin E.
    Kushner, David M.
    Zheng, Yanmei
    BMC WOMENS HEALTH, 2015, 15
  • [43] Uterine rupture following prostaglandins use in second trimester medical abortion: Fact or fiction? A systematic review
    Malvasi, Antonio
    Tinelli, Andrea
    Mulone, Vanessa
    Cicinelli, Ettore
    Vitagliano, Amerigo
    Damiani, Gianluca Raffaello
    Baldini, Giorgio Maria
    Dellino, Miriam
    D'Amato, Antonio
    Vimercati, Antonella
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2025, 168 (03) : 875 - 892
  • [44] Second-Trimester Medical Abortion with Misoprostol Preceded by Two Sequential Doses of Mifepristone: An Observational Study
    Shantikumar, Usham
    Bagga, Rashmi
    Kalra, Jasvinder
    Jain, Vanita
    Suri, Vanita
    Singh, Anju
    Choudhary, Neelam
    JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2022, 72 (SUPPL 1) : 26 - 35
  • [45] Second-trimester surgical abortion practices: a survey of National Abortion Federation members
    O'Connell, Katharine
    Jones, Heidi E.
    Lichtenberg, E. Steve
    Paul, Maureen
    CONTRACEPTION, 2008, 78 (06) : 492 - 499
  • [46] Rupture of the cervix in a sulprostone induced abortion in the second trimester
    F. Corrado
    R. D’Anna
    M. L. Cannata
    Archives of Gynecology and Obstetrics, 2000, 264 : 162 - 163
  • [47] Medical abortion in the late first trimester: a systematic review
    Kapp, Nathalie
    Eckersberger, Elisabeth
    Lavelanet, Antonella
    Rodriguez, Maria Isabel
    CONTRACEPTION, 2019, 99 (02) : 77 - 86
  • [48] Uterine rupture disguised by urinary retention following a second trimester induced abortion: a case report
    Qiaoying Jiang
    Liwei Yang
    Charles Ashley
    Erin E Medlin
    David M Kushner
    Yanmei Zheng
    BMC Women's Health, 15
  • [49] Combined vesicouterine rupture during second-trimester medical abortion for fetal abnormality after prior cesarean delivery: A case report
    Caruso, Giuseppe
    Paladini, Vanessa
    D'ambrosio, Valentina
    Giancotti, Antonella
    Piccioni, Maria Grazia
    Palaia, Innocenza
    Di Donato, Violante
    Perniola, Giorgia
    Brunelli, Roberto
    Pecorini, Francesco
    Muzii, Ludovico
    Scudo, Maria
    CASE REPORTS IN WOMENS HEALTH, 2021, 32
  • [50] SECOND TRIMESTER ABORTION: MIFEPRISTONE PLUS MISOPROSTOL vs. MISOPROSTOL PLUS OXYTOCIN
    Petca, Aida
    Zvanca, Mona
    Bot, Mihaela
    Petca, Razvan-Cosmin
    Mehedintu, Claudia
    Negoita, Silvius
    Maru, Nicoleta
    FARMACIA, 2019, 67 (05) : 850 - 856